Literature DB >> 6439551

Investigation of sex hormones in male epileptic patients.

E Rodin, M G Subramanian, J Gilroy.   

Abstract

Testosterone (T), follicle-stimulating hormone (FSH), luteinizing hormone (LH), and prolactin (PRL) levels were obtained in 33 male epileptic patients and 11 age-matched normal controls. The patients had significantly higher mean levels of FSH, LH, and PRL; T was decreased but not significantly so. Patients who had reported difficulties with sexual arousal on the Bear-Fedio Inventory had significantly lower T levels than those who did not. Increased LH levels correlated with younger age at onset of epilepsy and longer history of tonic clonic seizures. Increased PRL levels were related to a positive family history of epilepsy and nonfocal tonic clonic seizures. Anticonvulsant levels were unrelated to hormonal changes except for carbamazepine which was positively correlated with PRL levels.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6439551     DOI: 10.1111/j.1528-1157.1984.tb03478.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  4 in total

1.  Gynaecomastia induced by phenytoin in men with epilepsy.

Authors:  J P Monson; D F Scott
Journal:  Br Med J (Clin Res Ed)       Date:  1987-03-07

2.  Endocrine function changes in young males during long-term antiepileptic therapy with phenobarbitone and carbamazepine.

Authors:  L Rozza; A Marcolla; G Ferrari
Journal:  Ital J Neurol Sci       Date:  1987-08

3.  Luteinizing hormone pulsatile secretion and pituitary response to gonadotropin releasing hormone and to thyrotropin releasing hormone in male epileptic subjects on chronic phenobarbital treatment.

Authors:  G Murialdo; R Manni; A De Maria; M L Bonura; A Polleri; A Tartara
Journal:  J Endocrinol Invest       Date:  1987-02       Impact factor: 4.256

Review 4.  Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy.

Authors:  Jouko I T Isojärvi; Erik Taubøll; Andrew G Herzog
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.